| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.068 | 0.2 |